<table id="a21f-0800200c9a66-pct3" width="900" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3: Major Outcomes of the NSABP P-1 Trial</caption>
<tfoot>
<tr>
<td colspan="7">* Two women had hip and wrist fractures</td>
</tr>
<tr>
<td colspan="7">† Includes Colles' and other lower radius fractures</td>
</tr>
<tr>
<td colspan="7">‡ Requiring angioplasty or CABG</td>
</tr>
<tr>
<td colspan="7">§  New Q-wave on ECG; no angina or elevation of serum enzymes; or angina requiring hospitalization without surgery</td>
</tr>
<tr>
<td colspan="7">¶ Updated long-term follow-up data (median 6.9 years) from NSABP P-1 study added after cut-off for the other information in this table.</td>
</tr>
<tr>
<td colspan="7"># Seven cases were fatal; three in the placebo group and four in the tamoxifen group</td>
</tr>
<tr>
<td colspan="7">Þ Three cases in the tamoxifen group were fatal</td>
</tr>
<tr>
<td colspan="7">ß All but three cases in each group required hospitalization</td>
</tr>
<tr>
<td colspan="7">à Based on women without cataracts at baseline (6,230 Placebo, 6,199 Tamoxifen)</td>
</tr>
<tr>
<td colspan="7">è All women (6,707 Placebo, 6,681 Tamoxifen)</td>
</tr>
</tfoot>
<tbody>
<tr>
<th align="left" valign="top">TYPE OF EVENT</th>
<th align="center" colspan="2" stylecode="Botrule" valign="top"># OF EVENTS</th>
<td align="center" stylecode="Botrule" valign="top"> </td>
<th align="center" colspan="2" stylecode="Botrule" valign="top">RATE/1,000 <br/>WOMEN/YEAR</th>
<th align="center" valign="top">RR</th>
<th align="center" valign="top">95% CI LIMITS</th>
</tr>
<tr stylecode="Botrule">
<th align="center"> </th>
<th align="center">PLACEBO</th>
<th align="center">TAMOXIFEN</th>
<td align="center"> </td>
<th align="center">PLACEBO</th>
<th align="center">TAMOXIFEN</th>
<th align="center"> </th>
<th align="center"> </th>
</tr>
<tr stylecode="Botrule">
<td align="left">Invasive Breast Cancer</td>
<td align="center">156</td>
<td align="center">86</td>
<td align="center"> </td>
<td align="center">6.49</td>
<td align="center">3.58</td>
<td align="center">0.56</td>
<td align="center">0.43 to 0.72</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Age ≤ 49</td>
<td align="center">59</td>
<td align="center">38</td>
<td align="center"> </td>
<td align="center">6.34</td>
<td align="center">4.11</td>
<td align="center">0.65</td>
<td align="center">0.43 to 0.98</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Age 50 to 59</td>
<td align="center">46</td>
<td align="center">25</td>
<td align="center"> </td>
<td align="center">6.31</td>
<td align="center">3.53</td>
<td align="center">0.56</td>
<td align="center">0.35 to 0.91</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Age ≥ 60</td>
<td align="center">51</td>
<td align="center">23</td>
<td align="center"> </td>
<td align="center">7.17</td>
<td align="center">3.22</td>
<td align="center">0.45</td>
<td align="center">0.27 to 0.74</td>
</tr>
<tr stylecode="Botrule">
<td align="left" colspan="8">Risk Factors for Breast Cancer History, LCIS</td>
</tr>
<tr stylecode="Botrule">
<td align="left">No</td>
<td align="center">140</td>
<td align="center">78</td>
<td align="center"> </td>
<td align="center">6.23</td>
<td align="center">3.51</td>
<td align="center">0.56</td>
<td align="center">0.43 to 0.74</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Yes</td>
<td align="center">16</td>
<td align="center">8</td>
<td align="center"> </td>
<td align="center">12.73</td>
<td align="center">6.33</td>
<td align="center">0.50</td>
<td align="center">0.21 to 1.17</td>
</tr>
<tr stylecode="Botrule">
<td align="left" colspan="8">History, Atypical Hyperplasia</td>
</tr>
<tr stylecode="Botrule">
<td align="left">No</td>
<td align="center">138</td>
<td align="center">84</td>
<td align="center"> </td>
<td align="center">6.37</td>
<td align="center">3.89</td>
<td align="center">0.61</td>
<td align="center">0.47 to 0.80</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Yes</td>
<td align="center">18</td>
<td align="center">2</td>
<td align="center"> </td>
<td align="center">8.69</td>
<td align="center">1.05</td>
<td align="center">0.12</td>
<td align="center">0.03 to 0.52</td>
</tr>
<tr stylecode="Botrule">
<td align="left" colspan="8">No. First Degree Relatives</td>
</tr>
<tr stylecode="Botrule">
<td align="left">0</td>
<td align="center">32</td>
<td align="center">17</td>
<td align="center"> </td>
<td align="center">5.97</td>
<td align="center">3.26</td>
<td align="center">0.55</td>
<td align="center">0.30 to 0.98</td>
</tr>
<tr stylecode="Botrule">
<td align="left">1</td>
<td align="center">80</td>
<td align="center">45</td>
<td align="center"> </td>
<td align="center">5.81</td>
<td align="center">3.31</td>
<td align="center">0.57</td>
<td align="center">0.40 to 0.82</td>
</tr>
<tr stylecode="Botrule">
<td align="left">2</td>
<td align="center">35</td>
<td align="center">18</td>
<td align="center"> </td>
<td align="center">8.92</td>
<td align="center">4.67</td>
<td align="center">0.52</td>
<td align="center">0.30 to 0.92</td>
</tr>
<tr stylecode="Botrule">
<td align="left">≥ 3</td>
<td align="center">9</td>
<td align="center">6</td>
<td align="center"> </td>
<td align="center">13.33</td>
<td align="center">7.58</td>
<td align="center">0.57</td>
<td align="center">0.20 to 1.59</td>
</tr>
<tr stylecode="Botrule">
<td align="left" colspan="8">5 Year Predicted Breast Cancer Risk (as calculated by the Gail Model)</td>
</tr>
<tr stylecode="Botrule">
<td align="left">≤ 2.00%</td>
<td align="center">31</td>
<td align="center">13</td>
<td align="center"> </td>
<td align="center">5.36</td>
<td align="center">2.26</td>
<td align="center">0.42</td>
<td align="center">0.22 to 0.81</td>
</tr>
<tr stylecode="Botrule">
<td align="left">2.01 to 3.00%</td>
<td align="center">39</td>
<td align="center">28</td>
<td align="center"> </td>
<td align="center">5.25</td>
<td align="center">3.83</td>
<td align="center">0.73</td>
<td align="center">0.45 to 1.18</td>
</tr>
<tr stylecode="Botrule">
<td align="left">3.01 to 5.00%</td>
<td align="center">36</td>
<td align="center">26</td>
<td align="center"> </td>
<td align="center">5.37</td>
<td align="center">4.06</td>
<td align="center">0.76</td>
<td align="center">0.46 to 1.26</td>
</tr>
<tr stylecode="Botrule">
<td align="left">≥ 5.00%</td>
<td align="center">50</td>
<td align="center">19</td>
<td align="center"> </td>
<td align="center">13.15</td>
<td align="center">4.71</td>
<td align="center">0.36</td>
<td align="center">0.21 to 0.61</td>
</tr>
<tr stylecode="Botrule">
<td align="left">DCIS</td>
<td align="center">35</td>
<td align="center">23</td>
<td align="center"> </td>
<td align="center">1.47</td>
<td align="center">0.97</td>
<td align="center">0.66</td>
<td align="center">0.39 to 1.11</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Fractures (protocol-specified sites)</td>
<td align="center">92*</td>
<td align="center">76*</td>
<td align="center"> </td>
<td align="center">3.87</td>
<td align="center">3.20</td>
<td align="center">0.61</td>
<td align="center">0.83 to 1.12</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Hip</td>
<td align="center">20</td>
<td align="center">9</td>
<td align="center"> </td>
<td align="center">0.84</td>
<td align="center">0.38</td>
<td align="center">0.45</td>
<td align="center">0.18 to 1.04</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Wrist <sup>†</sup>
</td>
<td align="center">74</td>
<td align="center">69</td>
<td align="center"> </td>
<td align="center">3.11</td>
<td align="center">2.91</td>
<td align="center">0.93</td>
<td align="center">0.67 to 1.29</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Total Ischemic Events</td>
<td align="center">59</td>
<td align="center">61</td>
<td align="center"> </td>
<td align="center">2.47</td>
<td align="center">2.57</td>
<td align="center">1.04</td>
<td align="center">0.71 to 1.51</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Myocardial Infarction</td>
<td align="center">27</td>
<td align="center">27</td>
<td align="center"> </td>
<td align="center">1.13</td>
<td align="center">1.13</td>
<td align="center">1.00</td>
<td align="center">0.57 to 1.78</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Fatal</td>
<td align="center">8</td>
<td align="center">7</td>
<td align="center"> </td>
<td align="center">0.33</td>
<td align="center">0.29</td>
<td align="center">0.88</td>
<td align="center">0.27 to 2.77</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Nonfatal</td>
<td align="center">19</td>
<td align="center">20</td>
<td align="center"> </td>
<td align="center">0.79</td>
<td align="center">0.84</td>
<td align="center">1.06</td>
<td align="center">0.54 to 2.09</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Angina<sup>‡</sup>
</td>
<td align="center">12</td>
<td align="center">12</td>
<td align="center"> </td>
<td align="center">0.50</td>
<td align="center">0.50</td>
<td align="center">1.00</td>
<td align="center">0.41 to 2.44</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Acute Ischemic Syndrome<sup>§</sup>
</td>
<td align="center">20</td>
<td align="center">22</td>
<td align="center"> </td>
<td align="center">0.84</td>
<td align="center">0.92</td>
<td align="center">1.11</td>
<td align="center">0.58 to 2.13</td>
</tr>
<tr stylecode="Botrule">
<td align="left" valign="top">Uterine Malignancies (among women with an intact uterus)<sup>¶</sup>
</td>
<td align="center" valign="top">17</td>
<td align="center" valign="top">57</td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
</tr>
<tr stylecode="Botrule">
<td align="left">Endometrial Adenocarcinoma<sup>¶</sup>
</td>
<td align="center">17</td>
<td align="center">53</td>
<td align="center"> </td>
<td align="center">0.71</td>
<td align="center">2.20</td>
<td align="center"> </td>
<td align="center"> </td>
</tr>
<tr stylecode="Botrule">
<td align="left">Uterine Sarcoma<sup>¶</sup>
</td>
<td align="center">0</td>
<td align="center">4</td>
<td align="center"> </td>
<td align="center">0.0</td>
<td align="center">0.17</td>
<td align="center"> </td>
<td align="center"> </td>
</tr>
<tr stylecode="Botrule">
<td align="left">Stroke<sup># </sup>
</td>
<td align="center">24</td>
<td align="center">34</td>
<td align="center"> </td>
<td align="center">1.00</td>
<td align="center">1.43</td>
<td align="center">1.42</td>
<td align="center">0.82 to 2.51</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Transient Ischemic Attack</td>
<td align="center">21</td>
<td align="center">18</td>
<td align="center"> </td>
<td align="center">0.88</td>
<td align="center">0.75</td>
<td align="center">0.86</td>
<td align="center">0.43 to 1.70</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Pulmonary Emboli<sup>Þ</sup>
</td>
<td align="center">6</td>
<td align="center">18</td>
<td align="center"> </td>
<td align="center">0.25</td>
<td align="center">0.75</td>
<td align="center">3.01</td>
<td align="center">1.15 to 9.27</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Deep-Vein Thrombosis<sup>ß</sup>
</td>
<td align="center">19</td>
<td align="center">30</td>
<td align="center"> </td>
<td align="center">0.79</td>
<td align="center">1.26</td>
<td align="center">1.59</td>
<td align="center">0.86 to 2.98</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Cataracts Developing on Study<sup>à</sup>
</td>
<td align="center">483</td>
<td align="center">540</td>
<td align="center"> </td>
<td align="center">22.51</td>
<td align="center">25.41</td>
<td align="center">1.13</td>
<td align="center">1.00 to 1.28</td>
</tr>
<tr stylecode="Botrule">
<td align="left">Underwent Cataract Surgery<sup>à</sup>
</td>
<td align="center">63</td>
<td align="center">101</td>
<td align="center"> </td>
<td align="center">2.83</td>
<td align="center">4.57</td>
<td align="center">1.62</td>
<td align="center">1.18 to 2.22</td>
</tr>
<tr>
<td align="left">Underwent Cataract Surgery<sup>è</sup>
</td>
<td align="center">129</td>
<td align="center">201</td>
<td align="center"> </td>
<td align="center">5.44</td>
<td align="center">8.56</td>
<td align="center">1.58</td>
<td align="center">1.26 to 1.97</td>
</tr>
</tbody>
</table>